+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Probiotics Market in US 2024-2028

  • PDF Icon

    Report

  • 146 Pages
  • February 2024
  • Region: United States
  • TechNavio
  • ID: 5952371
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The probiotics market in US is forecasted to grow by USD 4.98 bn during 2023-2028, accelerating at a CAGR of 8.16% during the forecast period. The report on the probiotics market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the health benefits of probiotics, expansion in the retail landscape, and increasing online sales of probiotics in US.

The probiotics market in US is segmented as below:

By Distribution Channel

  • Offline
  • Online

By End-user

  • Human probiotics
  • Animal probiotics

By Product

  • Probiotic functional food and beverage
  • Supplements
  • Animal feed
This study identifies the increasing application of probiotics in the cosmetic industry as one of the prime reasons driving the probiotics market in US growth during the next few years. Also, increasing M and A activities by vendors in the probiotics market and increasing the launch of new probiotics will lead to sizable demand in the market.

The report on the probiotics market in US covers the following areas:

  • Probiotics market in US sizing
  • Probiotics market in US forecast
  • Probiotics market in US industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading probiotics market in US vendors that include BioGaia AB, Chr Hansen Holding AS, CUSTOM PROBIOTICS Inc., Danone, DuPont de Nemours Inc., General Mills Inc., InnovixLabs, Jarrow Formulas Inc., Koninklijke DSM NV, Lallemand Inc., Lifeway Foods Inc., Nestle SA, NOW Health Group Inc., Otsuka Holdings Co. Ltd., PepsiCo Inc., Reckitt Benckiser Group Plc, SFI Health, Swanson Health Products Inc., Symrise AG, The Procter and Gamble Co., Thorne HealthTech Inc., Twinlab Consolidated Holdings Inc., and Yakult Honsha Co. Ltd.. Also, the probiotics market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 10: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 11: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 12: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 13: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 14: Chart on US: Year-over-year growth 2023-2028 (%)
Exhibit 15: Data Table on US: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Probiotics market in US 2018 - 2022
Exhibit 16: Historic Market Size - Data Table on probiotics market in US 2018 - 2022 ($ billion)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 17: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 18: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 26: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 27: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 28: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 29: Chart on Comparison by Distribution Channel
Exhibit 30: Data Table on Comparison by Distribution Channel
6.3 Offline - Market size and forecast 2023-2028
Exhibit 31: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 32: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 33: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibit 34: Data Table on Offline - Year-over-year growth 2023-2028 (%)
6.4 Online - Market size and forecast 2023-2028
Exhibit 35: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 37: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibit 38: Data Table on Online - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Distribution Channel
Exhibit 39: Market opportunity by Distribution Channel ($ billion)
Exhibit 40: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 41: Chart on End-user - Market share 2023-2028 (%)
Exhibit 42: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 43: Chart on Comparison by End-user
Exhibit 44: Data Table on Comparison by End-user
7.3 Human probiotics - Market size and forecast 2023-2028
Exhibit 45: Chart on Human probiotics - Market size and forecast 2023-2028 ($ billion)
Exhibit 46: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Chart on Human probiotics - Year-over-year growth 2023-2028 (%)
Exhibit 48: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%)
7.4 Animal probiotics - Market size and forecast 2023-2028
Exhibit 49: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%)
Exhibit 52: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Exhibit 53: Market opportunity by End-user ($ billion)
Exhibit 54: Data Table on Market opportunity by End-user ($ billion)
8 Market Segmentation by Product
8.1 Market segments
Exhibit 55: Chart on Product - Market share 2023-2028 (%)
Exhibit 56: Data Table on Product - Market share 2023-2028 (%)
8.2 Comparison by Product
Exhibit 57: Chart on Comparison by Product
Exhibit 58: Data Table on Comparison by Product
8.3 Probiotic functional food and beverage - Market size and forecast 2023-2028
Exhibit 59: Chart on Probiotic functional food and beverage - Market size and forecast 2023-2028 ($ billion)
Exhibit 60: Data Table on Probiotic functional food and beverage - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Chart on Probiotic functional food and beverage - Year-over-year growth 2023-2028 (%)
Exhibit 62: Data Table on Probiotic functional food and beverage - Year-over-year growth 2023-2028 (%)
8.4 Supplements - Market size and forecast 2023-2028
Exhibit 63: Chart on Supplements - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on Supplements - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on Supplements - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on Supplements - Year-over-year growth 2023-2028 (%)
8.5 Animal feed - Market size and forecast 2023-2028
Exhibit 67: Chart on Animal feed - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Animal feed - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Animal feed - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Animal feed - Year-over-year growth 2023-2028 (%)
8.6 Market opportunity by Product
Exhibit 71: Market opportunity by Product ($ billion)
Exhibit 72: Data Table on Market opportunity by Product ($ billion)
9 Customer Landscape
9.1 Customer landscape overview
Exhibit 73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 74: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 75: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 76: Overview on factors of disruption
11.4 Industry risks
Exhibit 77: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 78: Vendors covered
12.2 Market positioning of vendors
Exhibit 79: Matrix on vendor position and classification
12.3 BioGaia AB
Exhibit 80: BioGaia AB - Overview
Exhibit 81: BioGaia AB - Business segments
Exhibit 82: BioGaia AB - Key news
Exhibit 83: BioGaia AB - Key offerings
Exhibit 84: BioGaia AB - Segment focus
12.4 Chr Hansen Holding AS
Exhibit 85: Chr Hansen Holding AS - Overview
Exhibit 86: Chr Hansen Holding AS - Business segments
Exhibit 87: Chr Hansen Holding AS - Key news
Exhibit 88: Chr Hansen Holding AS - Key offerings
Exhibit 89: Chr Hansen Holding AS - Segment focus
12.5 Danone
Exhibit 90: Danone - Overview
Exhibit 91: Danone - Business segments
Exhibit 92: Danone - Key news
Exhibit 93: Danone - Key offerings
Exhibit 94: Danone - Segment focus
12.6 DuPont de Nemours Inc.
Exhibit 95: DuPont de Nemours Inc. - Overview
Exhibit 96: DuPont de Nemours Inc. - Business segments
Exhibit 97: DuPont de Nemours Inc. - Key news
Exhibit 98: DuPont de Nemours Inc. - Key offerings
Exhibit 99: DuPont de Nemours Inc. - Segment focus
12.7 Koninklijke DSM NV
Exhibit 100: Koninklijke DSM NV - Overview
Exhibit 101: Koninklijke DSM NV - Business segments
Exhibit 102: Koninklijke DSM NV - Key news
Exhibit 103: Koninklijke DSM NV - Key offerings
Exhibit 104: Koninklijke DSM NV - Segment focus
12.8 Lallemand Inc.
Exhibit 105: Lallemand Inc. - Overview
Exhibit 106: Lallemand Inc. - Product / Service
Exhibit 107: Lallemand Inc. - Key offerings
12.9 Lifeway Foods Inc.
Exhibit 108: Lifeway Foods Inc. - Overview
Exhibit 109: Lifeway Foods Inc. - Product / Service
Exhibit 110: Lifeway Foods Inc. - Key offerings
12.10 Nestle SA
Exhibit 111: Nestle SA - Overview
Exhibit 112: Nestle SA - Business segments
Exhibit 113: Nestle SA - Key news
Exhibit 114: Nestle SA - Key offerings
Exhibit 115: Nestle SA - Segment focus
12.11 NOW Health Group Inc.
Exhibit 116: NOW Health Group Inc. - Overview
Exhibit 117: NOW Health Group Inc. - Product / Service
Exhibit 118: NOW Health Group Inc. - Key offerings
12.12 Otsuka Holdings Co. Ltd.
Exhibit 119: Otsuka Holdings Co. Ltd. - Overview
Exhibit 120: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 121: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 122: Otsuka Holdings Co. Ltd. - Segment focus
12.13 PepsiCo Inc.
Exhibit 123: PepsiCo Inc. - Overview
Exhibit 124: PepsiCo Inc. - Business segments
Exhibit 125: PepsiCo Inc. - Key news
Exhibit 126: PepsiCo Inc. - Key offerings
Exhibit 127: PepsiCo Inc. - Segment focus
12.14 Reckitt Benckiser Group Plc
Exhibit 128: Reckitt Benckiser Group Plc - Overview
Exhibit 129: Reckitt Benckiser Group Plc - Business segments
Exhibit 130: Reckitt Benckiser Group Plc - Key offerings
Exhibit 131: Reckitt Benckiser Group Plc - Segment focus
12.15 Symrise AG
Exhibit 132: Symrise AG - Overview
Exhibit 133: Symrise AG - Business segments
Exhibit 134: Symrise AG - Key offerings
Exhibit 135: Symrise AG - Segment focus
12.16 The Procter and Gamble Co.
Exhibit 136: The Procter and Gamble Co. - Overview
Exhibit 137: The Procter and Gamble Co. - Business segments
Exhibit 138: The Procter and Gamble Co. - Key news
Exhibit 139: The Procter and Gamble Co. - Key offerings
Exhibit 140: The Procter and Gamble Co. - Segment focus
12.17 Yakult Honsha Co. Ltd.
Exhibit 141: Yakult Honsha Co. Ltd. - Overview
Exhibit 142: Yakult Honsha Co. Ltd. - Business segments
Exhibit 143: Yakult Honsha Co. Ltd. - Key offerings
Exhibit 144: Yakult Honsha Co. Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 145: Inclusions checklist
Exhibit 146: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 147: Currency conversion rates for US$
13.4 Research methodology
Exhibit 148: Research methodology
Exhibit 149: Validation techniques employed for market sizing
Exhibit 150: Information sources
13.5 List of abbreviations
Exhibit 151: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Vendor Market Positioning
Exhibits 8: Parent market
Exhibits 9: Market Characteristics
Exhibits 10: Offerings of vendors included in the market definition
Exhibits 11: Market segments
Exhibits 12: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 13: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 14: Chart on US: Year-over-year growth 2023-2028 (%)
Exhibits 15: Data Table on US: Year-over-year growth 2023-2028 (%)
Exhibits 16: Historic Market Size - Data Table on probiotics market in US 2018 - 2022 ($ billion)
Exhibits 17: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits 18: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits 20: Five forces analysis - Comparison between 2023 and 2028
Exhibits 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 23: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 24: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 25: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 26: Chart on Market condition - Five forces 2023 and 2028
Exhibits 27: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 28: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 29: Chart on Comparison by Distribution Channel
Exhibits 30: Data Table on Comparison by Distribution Channel
Exhibits 31: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibits 32: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibits 33: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits 34: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits 35: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits 37: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits 39: Market opportunity by Distribution Channel ($ billion)
Exhibits 40: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 41: Chart on End-user - Market share 2023-2028 (%)
Exhibits 42: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 43: Chart on Comparison by End-user
Exhibits 44: Data Table on Comparison by End-user
Exhibits 45: Chart on Human probiotics - Market size and forecast 2023-2028 ($ billion)
Exhibits 46: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ billion)
Exhibits 47: Chart on Human probiotics - Year-over-year growth 2023-2028 (%)
Exhibits 48: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%)
Exhibits 49: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ billion)
Exhibits 51: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%)
Exhibits 53: Market opportunity by End-user ($ billion)
Exhibits 54: Data Table on Market opportunity by End-user ($ billion)
Exhibits 55: Chart on Product - Market share 2023-2028 (%)
Exhibits 56: Data Table on Product - Market share 2023-2028 (%)
Exhibits 57: Chart on Comparison by Product
Exhibits 58: Data Table on Comparison by Product
Exhibits 59: Chart on Probiotic functional food and beverage - Market size and forecast 2023-2028 ($ billion)
Exhibits 60: Data Table on Probiotic functional food and beverage - Market size and forecast 2023-2028 ($ billion)
Exhibits 61: Chart on Probiotic functional food and beverage - Year-over-year growth 2023-2028 (%)
Exhibits 62: Data Table on Probiotic functional food and beverage - Year-over-year growth 2023-2028 (%)
Exhibits 63: Chart on Supplements - Market size and forecast 2023-2028 ($ billion)
Exhibits 64: Data Table on Supplements - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Chart on Supplements - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on Supplements - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Animal feed - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Data Table on Animal feed - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Chart on Animal feed - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Animal feed - Year-over-year growth 2023-2028 (%)
Exhibits 71: Market opportunity by Product ($ billion)
Exhibits 72: Data Table on Market opportunity by Product ($ billion)
Exhibits 73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 74: Impact of drivers and challenges in 2023 and 2028
Exhibits 75: Overview on Criticality of inputs and Factors of differentiation
Exhibits 76: Overview on factors of disruption
Exhibits 77: Impact of key risks on business
Exhibits 78: Vendors covered
Exhibits 79: Matrix on vendor position and classification
Exhibits 80: BioGaia AB - Overview
Exhibits 81: BioGaia AB - Business segments
Exhibits 82: BioGaia AB - Key news
Exhibits 83: BioGaia AB - Key offerings
Exhibits 84: BioGaia AB - Segment focus
Exhibits 85: Chr Hansen Holding AS - Overview
Exhibits 86: Chr Hansen Holding AS - Business segments
Exhibits 87: Chr Hansen Holding AS - Key news
Exhibits 88: Chr Hansen Holding AS - Key offerings
Exhibits 89: Chr Hansen Holding AS - Segment focus
Exhibits 90: Danone - Overview
Exhibits 91: Danone - Business segments
Exhibits 92: Danone - Key news
Exhibits 93: Danone - Key offerings
Exhibits 94: Danone - Segment focus
Exhibits 95: DuPont de Nemours Inc. - Overview
Exhibits 96: DuPont de Nemours Inc. - Business segments
Exhibits 97: DuPont de Nemours Inc. - Key news
Exhibits 98: DuPont de Nemours Inc. - Key offerings
Exhibits 99: DuPont de Nemours Inc. - Segment focus
Exhibits 100: Koninklijke DSM NV - Overview
Exhibits 101: Koninklijke DSM NV - Business segments
Exhibits 102: Koninklijke DSM NV - Key news
Exhibits 103: Koninklijke DSM NV - Key offerings
Exhibits 104: Koninklijke DSM NV - Segment focus
Exhibits 105: Lallemand Inc. - Overview
Exhibits 106: Lallemand Inc. - Product / Service
Exhibits 107: Lallemand Inc. - Key offerings
Exhibits 108: Lifeway Foods Inc. - Overview
Exhibits 109: Lifeway Foods Inc. - Product / Service
Exhibits 110: Lifeway Foods Inc. - Key offerings
Exhibits 111: Nestle SA - Overview
Exhibits 112: Nestle SA - Business segments
Exhibits 113: Nestle SA - Key news
Exhibits 114: Nestle SA - Key offerings
Exhibits 115: Nestle SA - Segment focus
Exhibits 116: NOW Health Group Inc. - Overview
Exhibits 117: NOW Health Group Inc. - Product / Service
Exhibits 118: NOW Health Group Inc. - Key offerings
Exhibits 119: Otsuka Holdings Co. Ltd. - Overview
Exhibits 120: Otsuka Holdings Co. Ltd. - Business segments
Exhibits 121: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits 122: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits 123: PepsiCo Inc. - Overview
Exhibits 124: PepsiCo Inc. - Business segments
Exhibits 125: PepsiCo Inc. - Key news
Exhibits 126: PepsiCo Inc. - Key offerings
Exhibits 127: PepsiCo Inc. - Segment focus
Exhibits 128: Reckitt Benckiser Group Plc - Overview
Exhibits 129: Reckitt Benckiser Group Plc - Business segments
Exhibits 130: Reckitt Benckiser Group Plc - Key offerings
Exhibits 131: Reckitt Benckiser Group Plc - Segment focus
Exhibits 132: Symrise AG - Overview
Exhibits 133: Symrise AG - Business segments
Exhibits 134: Symrise AG - Key offerings
Exhibits 135: Symrise AG - Segment focus
Exhibits 136: The Procter and Gamble Co. - Overview
Exhibits 137: The Procter and Gamble Co. - Business segments
Exhibits 138: The Procter and Gamble Co. - Key news
Exhibits 139: The Procter and Gamble Co. - Key offerings
Exhibits 140: The Procter and Gamble Co. - Segment focus
Exhibits 141: Yakult Honsha Co. Ltd. - Overview
Exhibits 142: Yakult Honsha Co. Ltd. - Business segments
Exhibits 143: Yakult Honsha Co. Ltd. - Key offerings
Exhibits 144: Yakult Honsha Co. Ltd. - Segment focus
Exhibits 145: Inclusions checklist
Exhibits 146: Exclusions checklist
Exhibits 147: Currency conversion rates for US$
Exhibits 148: Research methodology
Exhibits 149: Validation techniques employed for market sizing
Exhibits 150: Information sources
Exhibits 151: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the probiotics market in US: BioGaia AB, Chr Hansen Holding AS, CUSTOM PROBIOTICS Inc., Danone, DuPont de Nemours Inc., General Mills Inc., InnovixLabs, Jarrow Formulas Inc., Koninklijke DSM NV, Lallemand Inc., Lifeway Foods Inc., Nestle SA, NOW Health Group Inc., Otsuka Holdings Co. Ltd., PepsiCo Inc., Reckitt Benckiser Group Plc, SFI Health, Swanson Health Products Inc., Symrise AG, The Procter and Gamble Co., Thorne HealthTech Inc., Twinlab Consolidated Holdings Inc., and Yakult Honsha Co. Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing application of probiotics in the cosmetic industry."

According to the report, one of the major drivers for this market is the health benefits of probiotics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BioGaia AB
  • Chr Hansen Holding AS
  • CUSTOM PROBIOTICS Inc.
  • Danone
  • DuPont de Nemours Inc.
  • General Mills Inc.
  • InnovixLabs
  • Jarrow Formulas Inc.
  • Koninklijke DSM NV
  • Lallemand Inc.
  • Lifeway Foods Inc.
  • Nestle SA
  • NOW Health Group Inc.
  • Otsuka Holdings Co. Ltd.
  • PepsiCo Inc.
  • Reckitt Benckiser Group Plc
  • SFI Health
  • Swanson Health Products Inc.
  • Symrise AG
  • The Procter and Gamble Co.
  • Thorne HealthTech Inc.
  • Twinlab Consolidated Holdings Inc.
  • Yakult Honsha Co. Ltd.